UM Ventures News
Three Recent UM Baltimore Start-Ups Enter Commercial Phase
Tuesday, October 15, 2013
UMB Licensee Countervail Wins $343,000 Grant to Support Drug Research
Monday, October 14, 2013
Why Brain Surgeons Want Help From A Maggot-Like Robot
Saturday, October 5, 2013
![Gliknik Gliknik](https://www.umventures.org/sites/default/files/styles/medium/public/gliknik_logo.png?itok=9zgokTf-)
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases
Monday, September 30, 2013
![MedImmune and USM MedImmune and USM](https://www.umventures.org/sites/default/files/styles/medium/public/medimmune.png?itok=tRjx5EVj)
MedImmune, UMB ink $6 million research partnership
Wednesday, September 25, 2013
![Profectus BioSciences Profectus BioSciences](https://www.umventures.org/sites/default/files/styles/medium/public/profectus_logo.png?itok=l80eiKd3)
Profectus BioSciences Presents Data at Filovirus Medical Countermeasures Meeting
Monday, September 23, 2013
![Redox Power Systems Redox Power Systems](https://www.umventures.org/sites/default/files/styles/medium/public/redox_logo.png?itok=cpSbq6BD)
Redox Power Systems betting the future of electricity lies in fuel cells
Monday, August 19, 2013
UMB's Licensing Deals Fuel Local Life Sciences Community
Tuesday, August 6, 2013
![Rexahn Pharmaceuticals Rexahn Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/rexahn_logo.jpg?itok=CPnm_QUd)
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform
Wednesday, July 17, 2013